Automated Author Profile

M., Boldyreva

Current S-Index

1.3

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.7

Average Dataset Index per dataset

Total Datasets

2

Total datasets for this author

Average FAIR Score

13.5%

Average FAIR Score per dataset

Total Citations

2

Total citations to the author's datasets

Total Mentions

0

Total mentions of the author's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Supplementary Material for: Assessing urinary microbiota in chronic cystitis based on midstream urine sample.

Objectives: This study aims to compare the urinary microbiota of healthy women, women with a predisposition to UTIs and patients with chronic recurrent cystitis using real-time PCR as well as identify diagnostic markers for urinary diseases. Patients and methods: The study enrolled three groups of patients: healthy control group, patients with chronic recurrent cystitis and patients with a risk of developing UTIs. Urine samples were analyzed by multiplex real-time PCR reagent kits Femoflor®16 and BacScreen OM. Results: Chronic recurrent cystitis is associated with an increase in total bacterial mass (TBM), genomic DNA and relative predominance of facultative anaerobic microorganisms. The most prevalent bacterial species found in chronic cystitis was E. coli in conjunction with other Enterobacteriaceae, most commonly, Serratia marcescens. An increased amount of genomic DNA and both facultative and obligate anaerobic microorganisms was observed in patients with a risk of developing UTIs. A relative decrease in Lactobacillus spp. was noted in both groups, with the chronic cystitis group showing a more pronounced reduction. Conclusion: In summary, the levels of genomic DNA, TBM and relative values of Lactobacillus spp. can be used as molecular diagnostics markers for chronic cystitis and a variety of other conditions, including micronephrolithiasis and bacterial vaginosis.

Authors

  • karger, figshare admin ;
  • M., Boldyreva ;
  • M., Petrunicheva ;
  • A., Ivanova ;
  • A., Morozov ;
  • S., Koroleva ;
  • Z., Moskvina ;
  • S., Rossolovskaya ;
  • L., Spivak
1 Citation0 Mentions13% FAIR0.7 Dataset Index
10.6084/m9.figshare.29432159January 2025

Supplementary Material for: Assessing urinary microbiota in chronic cystitis based on midstream urine sample.

Objectives: This study aims to compare the urinary microbiota of healthy women, women with a predisposition to UTIs and patients with chronic recurrent cystitis using real-time PCR as well as identify diagnostic markers for urinary diseases. Patients and methods: The study enrolled three groups of patients: healthy control group, patients with chronic recurrent cystitis and patients with a risk of developing UTIs. Urine samples were analyzed by multiplex real-time PCR reagent kits Femoflor®16 and BacScreen OM. Results: Chronic recurrent cystitis is associated with an increase in total bacterial mass (TBM), genomic DNA and relative predominance of facultative anaerobic microorganisms. The most prevalent bacterial species found in chronic cystitis was E. coli in conjunction with other Enterobacteriaceae, most commonly, Serratia marcescens. An increased amount of genomic DNA and both facultative and obligate anaerobic microorganisms was observed in patients with a risk of developing UTIs. A relative decrease in Lactobacillus spp. was noted in both groups, with the chronic cystitis group showing a more pronounced reduction. Conclusion: In summary, the levels of genomic DNA, TBM and relative values of Lactobacillus spp. can be used as molecular diagnostics markers for chronic cystitis and a variety of other conditions, including micronephrolithiasis and bacterial vaginosis.

Authors

  • karger, figshare admin ;
  • M., Boldyreva ;
  • M., Petrunicheva ;
  • A., Ivanova ;
  • A., Morozov ;
  • S., Koroleva ;
  • Z., Moskvina ;
  • S., Rossolovskaya ;
  • L., Spivak
1 Citation0 Mentions13% FAIR0.7 Dataset Index
10.6084/m9.figshare.29432159.v1January 2025